| Status | Study |
| Recruiting |
Study Name: Krabbe Disease Global Patient Registry Condition: Krabbe Disease Date: 2016-12-06 |
| Recruiting |
Study Name: International Registry Study of Neutral Lipid Storage Disease (NLSD) / Triglyceride Deposit Cardiomyovasculopathy (TGCV) and Related Diseases Condition: Neutral Lipid Storage Disease Date: 2016-08-04 |
| Recruiting |
Study Name: Clinical Study on the Safety of CNT-02 for TGCV and NLSD-M Condition: Primary Triglyceride Deposit Cardiomyovasculopathy (TGCV) Neutral Lipi Date: 2016-07-06 Interventions: Dietary Supplement: CNT-02 Each subject will take 2.0g of the investigational product orally 3 times a d |
| Recruiting |
Study Name: Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy Condition: Metabolism, Inborn Errors Lipid Metabolism, Inborn Errors Date: 2015-12-09 Interventions: Other: Sugar 10 minutes before exercising, the subjects are given a bolus of glucose solution 0.2 g/kg i |
| Recruiting |
Study Name: LYSO-PROVE - Determine the Prognostic Value of Lyso-Gb1 for Monitoring the Progress of Gaucher Disease Condition: Lysosomal Storage Diseases Gaucher Disease Sphingolipidose Date: 2015-03-13 |
| Recruiting |
Study Name: Safety, Tolerability, PK, and Efficacy Evaluation of Repeat Ascending Doses of Olipudase Alfa in Pediatric Patients <18 Years of Age With Acid Sphingomyelinase Deficiency Condition: Sphingomyelin Lipidosis Date: 2014-11-07 Interventions: Drug: Olipudase alfa Pharmaceutical form: powder for concentrate for solution for infusion Route of admi |
| Withdrawn |
Study Name: Efficacy Study of Daily Pro-Omega LDL for Low-Density Lipoprotein Cholesterol and Triglyceride Reduction Condition: Mixed Hyperlipoproteinemia Date: 2014-02-20 Interventions: Dietary Supplement: Pro-Omega LDL Other: P |
| Completed |
Study Name: Evaluation of Antioxidant Activity of Oral Lutein in Preterm and Term Newborn Condition: Infant, Newborn, Diseases Other Lipid Storage Disorders Date: 2014-02-17 Interventions: Dietary Supplement: Lutein drops |
| Completed |
Study Name: A Pilot Study to Evaluate the Lipid Effects of TRIA-662 Condition: Hypertriglyceridemia Mixed Hyperlipidemia Date: 2013-12-06 Interventions: Drug: TRIA-662 Following Basel |
| Recruiting |
Study Name: A Long-Term Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency Condition: Sphingomyelin Lipidosis Date: 2013-11-26 Interventions: Drug: GZ402665 Pharmaceutical form: Powder for concentrate |